The path to self-driving: Leveraging agentic AI to drive the future of clinical drug development

Clinical development, not discovery, has become the defining bottleneck in biomedical innovation. Despite rising scientific investment, annual drug approvals have remained stubbornly flat for over a decade. The root cause is structural: fragmented systems, manual workflows, and reactive oversight that no longer scale to the demands of modern trial complexity.

This session charts the path from AI ambition to enterprise-scale deployment. We explore why agentic AI represents a fundamental shift in what's operationally possible in regulated clinical environments, what a structured activation journey looks like in practice, and what today's most capable clinical agents can already do.

Join us for this interactive session, which includes a live demo. Secure your spot today!

Key learnings:

Why clinical operations are the critical bottleneck and how agentic AI, grounded in regulatory frameworks like 21 CFR Part 11 and ICH E6 R3, can expand operational capacity, reduce the systemic bottlenecks, and reshape the productivity curve of clinical development.
What "activation to scale" actually means, including the implementation journey from pilot to production, and how sprint activation compresses the path to measurable, enterprise-scale agent deployment.
How purpose-built clinical agents work in practice, where you’ll meet agents already primed for orchestration, such as Medable’s CRA, TMF, & PI Summary Agents, and more. See how they assist with risk detection, QTL monitoring, eCOA oversight, and compliance while acting as expert collaborators, not just tools.

First name

Last name

Company

Job Title

Country

State/Province

What’s the most significant factor causing delays in your clinical trials?

Poor patient engagement and protocol adherence

Site onboarding and protocol amendments

Data management and quality issues

Manual workflows and siloed systems

How prepared is your organization to move forward adopting agentic AI?

Still Exploring – Gathering knowledge and deciding on use cases

Focused on Pilots – Running early experiments, validating use cases

Scaling Up – Moving beyond pilots into production with a defined strategy.

All In – Dedicated teams, investment, and change management in motion

No cost to register, subject to confirmation

By registering for this event, you accept that you may receive direct communication from Endpoints News and/or the sponsor(s). View how we use your data here.

If you are experiencing problems with your registration, please try the Zoom registration page.

Andrew Mackinnon

SVP & Executive General Manager, Customer Value, Medable

Andrew brings over 20 years of experience managing clinical trials across large pharma, biotechs, and CROs. He leverages deep operational expertise to optimize the deployment of clinical trial technologies and decentralized methodologies. Having played a key role in one of the earliest implementations of decentralized trials, Andrew remains a passionate advocate for reducing the burden of research on both sites and patients and for simplifying and enhancing the experience for study teams. A seasoned drug development leader, he has a proven track record of driving strategic AI-powered transformation across multiple life sciences business areas through effective team mentorship, client collaboration, and change management.

Jena Daniels

VP, Customer Value - Site & Patient Engagement, Medable

Jena Daniels, VP of Customer Value, leads the end-to-end user journey strategy across Medable's clinical trial platform from onboarding and access, through adoption, to the measurable outcomes that define real customer value. A recognized voice in decentralized and hybrid clinical trials, Jena pioneered Medable's Patient Caregiver Network (PCN), growing it to more than 2,000 patient and caregiver advocates across 12 countries representing 67 health conditions. Her work on adoption strategy, change management, and trust frameworks for agentic clinical workflows is helping life sciences organizations bring emerging technology into real-world execution. Jena brings a research-grounded perspective to every stage of digital transformation, backed by 30+ peer-reviewed publications in ML/AI and remote patient monitoring, and hands-on experience spanning clinical operations, patient engagement, and product strategy. A former CRA and five-time clinical trial participant, she brings a rare ground-level perspective and an unwavering stance that the patient and site experience should be at the center of everything Medable builds.

Rana Khan

Senior Technical Sales Consultant, Medable

With nearly 13 years in the eCOA industry, Rana Khan has helped clients overcome clinical research challenges and maximize the impact of digital solutions. Now as a senior technical sales consultant at Medable, he partners with clients from the earliest stages, providing strategic insight and showcasing how Medable’s cutting-edge platform can transform their clinical trials.

moderator

Surani Fernando

Healthcare journalist, writer & podcaster

Surani Fernando is a seasoned healthcare journalist and editor with over 13 years experience covering the biopharma industry. A Sydney native, she started her investigative journalism career in London covering clinical trials, M&A and financing deals for BioPharm Insight, later moving to New York to continue her work as an enterprise journalist and editorial leader for GlobalData and Reorg. She is now based in Madrid working as a freelance journalist, consultant writer and podcast producer. In November 2023, she launched the Raising Biotech podcast.